BeiGene (BGNE) has entered into a settlement agreement with MSN Pharmaceuticals and MSN Laboratories Private resolving patent litigation ...

Generally, he added, the best value you’ll find are creams, and he’s a fan of Dollar Tree’s CareAll brand arthritis and ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The European Commission has fined Teva, the world’s largest generic drugmaker, €462.6mn for hindering ...

According to reports out of Korea, Samsung is exploring a new branding play for its Android smartphones that would be in addition to its iconic “Galaxy” name. The logic behind this would be to ...

Levitra Sullivant who is educated with a bachelor's degree, an ovarian cancer survivor, and a widow has been trying to make heads or tails out of the citations she has been receiving from the City of ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary ...

Regeneron Pharmaceutical (NASDAQ:REGN) fell 2% after a court rejected its request for a temporary injunction blocking sales of its generic Eylea by Amgen (AMGN). Amgen ticked higher by 0.4%.